TopFunds

Dexcom

NASDAQ: DXCM

Stock price

89.35 USD

(-36.54%) 5 years

Health Care EquipmentMedical - Devices

Insider Transactions

5Y price score: (50)
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: -36.54%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
15-sep.-26Sale(6,539)84.0(549,538)29,293AUGUSTINOS NICHOLASdirectorlink
15-sep.-26Sale(1,700)84.0(142,868)99,885Brown Michael Jonofficer: EVP Chief Legal Compliance Offlink
14-sep.-26Sale(1,550)84.0(130,231)35,832AUGUSTINOS NICHOLASdirectorlink
10-sep.-26Sale(3,638)83.3(302,936)146,828Sylvain Jereme Mofficer: EVP, Chief Financal Officerlink
10-sep.-26Award5,841--5,841Boehnlein Glenn Sdirectorlink
27-aug.-26Sale(2,565)88.4(226,669)126,043Stern Sadieofficer: EVP Chief People & Culture Offlink
20-aug.-26Sale(19,308)89.7(1,732,043)309,662SAYER KEVIN Rdirector, officer: Executive Chairlink
20-aug.-26Sale(7,351)90.8(667,332)302,311SAYER KEVIN Rdirector, officer: Executive Chairlink
20-aug.-26Sale(97)91.4(8,867)302,214SAYER KEVIN Rdirector, officer: Executive Chairlink
14-aug.-26Sale(1,700)91.9(156,281)102,953Brown Michael Jonofficer: EVP Chief Legal Compliance Offlink

54.1

52-week range

92.5

89.35

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

3.9 %

Dividend Yield TTM

-

Market cap $

$ 33,717

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

35.3

Price / Book TTM

13.1

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

0.7

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

17.9 %

(36.5) %

284.1 %

Free cash flow per share growth

(8) %

274.6 %

5,300.9 %

Earnings per share growth

42.2 %

64.6 %

1,261.1 %

Analyst ratings

Price Target Low

64

Price Target High

105

Price Target Median

92

Buy

42

Hold

8

Sell

2

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
(0.2)
(0.2)
(0.1)
(0.4)
0.3
1.3
0.5
0.8
1.3
1.4
2.1
-
0.7
0.9
1.1
1.4
1.7
1.8
02FCF per share
-
-
0.1
0.2
0.4
0.7
0.1
0.7
1.2
1.5
2.7
49%
1.6
2
2.6
3.2
4
3.4
03Dividends per share
Help
Adjusted for splitsLearn more
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
05Revenue
$ 402
$ 573.3
$ 718.5
$ 1,032
$ 1,476
$ 1,927
$ 2,449
$ 2,910
$ 3,622
$ 4,033
$ 4,662
27.8%
$ 5,957
$ 7,611
$ 9,725
$ 12,425
$ 15,876
$ 16,352
06ㅤ% Change
-
42.6%
25.3%
43.6%
43.1%
30.5%
27.1%
18.8%
24.5%
11.3%
15.6%
27.8%
27.8%
27.8%
27.8%
27.8%
27.8%
27.8%
07Net Income
(57.6)
(65.6)
(50.2)
(127.1)
101.1
493.6
216.9
341.2
541.5
576.2
836.3
-
298.6
381.6
487.6
623
796
819.8
08ㅤ% Margin
(14.3)%
(11.4)%
(7)%
(12.3)%
6.9%
25.6%
8.9%
11.7%
15%
14.3%
17.9%
5% A
5%
5%
5%
5%
5%
5%
09CFO
49
56.2
92
123.2
314.5
475.6
442.5
669.5
748.5
989.5
1,441
40.2%
1,137
1,452
1,856
2,371
3,030
3,121
10ㅤ% Of revenue
12.2%
9.8%
12.8%
11.9%
21.3%
24.7%
18.1%
23%
20.7%
24.5%
30.9%
19.1% A
19.1%
19.1%
19.1%
19.1%
19.1%
19.1%
11CAPEX
(33.3)
(55.7)
(66)
(67.1)
(180)
(199)
(389.2)
(364.8)
(236.6)
(358.8)
(363.5)
27%
(461.6)
(586.3)
(744.6)
(945.6)
(1,201)
(1,525)
12ㅤ% Change
-
67.3%
18.5%
1.7%
168.3%
10.6%
95.6%
(6.3)%
(35.1)%
51.7%
1.3%
27% A
27%
27%
27%
27%
27%
27%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
15.7
0.5
26
56.1
134.5
276.6
53.3
304.7
511.9
630.7
1,077
52.6%
675.1
866.1
1,111
1,426
1,829
1,595
14Total assets
292
402.8
904.1
1,916
2,395
4,291
4,933
5,392
6,265
6,485
6,340
36%
8,625
11,733
15,962
21,715
29,542
40,189
15ㅤ% Change
-
38%
124.5%
111.9%
25%
79.1%
15%
9.3%
16.2%
3.5%
(2.2)%
36%
36%
36%
36%
36%
36%
36%
16Total liabilities
70.8
119
484.7
1,253
1,512
2,464
2,891
3,260
4,196
4,382
3,594
48.1%
4,889
6,651
9,049
12,310
16,746
22,782
17ㅤ% Of assets
24.3%
29.5%
53.6%
65.4%
63.2%
57.4%
58.6%
60.5%
67%
67.6%
56.7%
56.7% A
56.7%
56.7%
56.7%
56.7%
56.7%
56.7%
18Shareholders Equity
221.2
283.8
419.4
663.3
882.6
1,827
2,042
2,132
2,069
2,103
2,746
28.6%
3,736
5,082
6,914
9,406
12,795
17,407
19Net Debt
(83.8)
(87.8)
(107.2)
(119.4)
713.9
1,022
1,105
1,503
2,028
1,981
472
-
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
319,200
334,400
345,200
352,800
369,200
390,000
428,800
427,500
425,500
412,700
405,500
2.4%
415,321
425,379
435,682
446,233
457,041
468,110
21ㅤ% Change
-
4.8%
3.2%
2.2%
4.7%
5.6%
10%
(0.3)%
(0.5)%
(3)%
(1.7)%
2.4%
2.4%
2.4%
2.4%
2.4%
2.4%
2.4%
22ROA
(19.7)%
(16.3)%
(5.6)%
(6.6)%
4.2%
11.5%
4.4%
6.3%
8.6%
8.9%
13.2%
-
3.5%
3.3%
3.1%
2.9%
2.7%
2%
23ROE
(26)%
(23.1)%
(12)%
(19.2)%
11.5%
27%
10.6%
16%
26.2%
27.4%
30.5%
-
8%
7.5%
7.1%
6.6%
6.2%
4.7%
24Interest coverage
(142.7)
(91.3)
(3.3)
(8.2)
2.4
3.5
14.1
21
29.4
31.6
49.8
-
-
-
-
-
-
-
25Dividend Yield
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
26P/E Ratio
(113.8)
(74.6)
(95.7)
(83.2)
195.3
70.6
239.7
128.7
86.2
53.3
31
-
-
-
-
-
-
-
27Stock price range
14-25
13-24
11-21
13-37
28-57
48-113
81-163
68-133
75-138
64-140
55-91
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
6,537
4,993
4,954
10,566
19,929
34,902
51,938
44,096
47,899
31,468
25,898
14.8%
17,952
19,795
21,821
24,051
26,503
-
29FCF Yield
0.2%
-
0.5%
0.5%
0.7%
0.8%
0.1%
0.7%
1.1%
2%
4.2%
33%
3.8%
4.4%
5.1%
5.9%
6.9%
-
30Average stock price
19.5
18.7
16.2
25.2
42.6
80.4
121.9
100.4
106.7
102.2
72.8
14.1%
43.2
46.5
50.1
53.9
58
-
31 CEO
JL
Jacob Steven Leach